Quantcast
Last updated on May 20, 2013 at 1:23 EDT

Latest Endocrinology Stories

2012-10-03 10:24:14

Kronos Early Estrogen Prevention Study results to help clinicians assess HT risk-benefits PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Kronos Longevity Research Institute (KLRI) today announced that a major finding of the Kronos Early Estrogen Prevention Study (KEEPS) indicates that hormone therapy (HT) improves symptoms of depression and anxiety in recently menopausal women, without adverse effects on cognition. The findings come as a result of a four-year randomized clinical...

2012-10-03 10:24:12

PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Estrogen/progesterone treatment started soon after menopause appears safe and relieves many of the symptoms menopausal women face as well as improving mood and markers of cardiovascular risk, according to a multicenter randomized study presented at the North American Menopause Society (NAMS) Annual Meeting in Orlando, Florida. "The KEEPS provides invaluable information for women close to menopause and their clinicians," said S....

2012-10-03 02:27:32

MENLO PARK, Calif., Oct. 3, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) announced today that it is presenting two abstracts from its Phase 3 clinical trial, BREEZE 3, at this week's 23(rd) Annual Meeting of the North American Menopause Society (NAMS) in Orlando, FL. The data showed that Serada(®), Depomed's investigational non-hormonal extended-release formulation of gabapentin, may help manage menopausal hot flashes. "Hot flashes are a disruptive problem affecting as many as...

2012-10-02 18:22:15

MIAMI, FL, NEW YORK, NY and ORLANDO, FL, Oct. 3, 2012 /PRNewswire/ -- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced positive results from two multicenter, double-blind, randomized, placebo-controlled Phase 3 clinical studies evaluating low-dose mesylate salt of paroxetine (LDMP; 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. Menopausal VMS, which comprise hot...

2012-10-01 02:31:36

SANTA FE, N.M., Oct. 1, 2012 /PRNewswire/ -- This story is a comparative analysis of the untold story of certain botanicals for Menopause, what risks they suggest, but most importantly, what the sellers are not telling women about the risks when they take these botanicals for Menopause, and not explaining why these ingredients do not have warning labels. Menopause affects 45 million women annually. Huge numbers! The story launched into the public four weeks ago via...

Fat Hormone May Play Role In Hearing, Vision Loss
2012-09-27 15:18:31

Lee Rannals for redOrbit.com – Your Universe Online A new study indicates that leptin, or the "fat hormone," may play a role in hearing and vision loss, on top of weight gain. Researchers wrote in the journal General and Comparative Endocrinology that leptin could ultimately help doctors better understand sensory loss in humans. During the study, the scientists were able to develop zebrafish that were able to produce low leptin. While studying the zebrafish, scientists assumed...

2012-09-25 18:20:42

BOCA RATON, Fla., Sept. 25, 2012 /PRNewswire/ -- Dr. Scott Fogle from Life Extension, an organization dedicated to the extension of the healthy human lifespan, will appear on The SUZANNE Show this week to discuss hormone imbalances in men. His appearance is one in a series of segments devoted to sexuality and the aging process. Dr. Fogle reveals the simple truth behind the male mid-life crisis, and just how easy it can be for men to get back to feeling like themselves again. Men over...

2012-09-24 22:20:46

SAN ANTONIO, Sept. 25, 2012 /PRNewswire/ -- Limitless Worldwide, LLC, is extremely proud to announce that it has secured the exclusive rights to distribute Somatodyne(TM), the trademark for a proprietary formula that was the subject of a presentation at the Obesity Society's prestigious 30(th) Annual Scientific Meeting. Some of the most cutting-edge obesity research in the world is included at this event, yet the presentation on this dietary supplement was one of the most...

2012-09-24 12:50:10

Melbourne researchers have identified a new way of protecting female fertility, offering hope to women whose fertility may be compromised by the side-effects of cancer therapy or by premature menopause. The researchers, from the Walter and Eliza Hall Institute, Monash University and Prince Henry's Institute of Medical Research, made the discovery while investigating how egg cells die. They found that two specific proteins, called PUMA and NOXA, cause the death of egg cells in the...

2012-09-24 06:22:56

FORT LAUDERDALE, Fla., Sept. 24, 2012 /PRNewswire/ -- Dr. Stacey Nottingham and Dr. Scott Fogle from Life Extension, a Fort Lauderdale, Fla.-based organization dedicated to the extension of the healthy human lifespan, will be guests on The Suzanne Show premiering this week on the Lifetime Network Wednesday, September 26 at 7 a.m. (ET/PT). (Photo: http://photos.prnewswire.com/prnh/20120924/CL79340) (Logo: http://photos.prnewswire.com/prnh/20120223/FL58611LOGO-b) Dr. Nottingham...


Latest Endocrinology Reference Libraries

Osteoporosis International
2012-05-17 15:25:40

Osteoporosis International is a peer-reviewed medical journal published monthly by Springer Science+Business Media. It was established in 1990. It is the official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. The journal includes original research on all areas of osteoporosis and related fields. It also publishes reviews, educational articles, and case reports. Editors-in-chief are R. Lindsay and J.A. Kanis. According to the Journal...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (2 articles) »